Clik here to view.
F45 Training Opens a New Chapter of Work-Life Balance for the Kwun Tong Workers
KWUN TONG, Hong Kong We are all aware of the importance of fitness activity. Many of us would like to participate, but we have a number of reservations. It seems difficult for workers to maintain a...
View ArticleClik here to view.
KBI Biopharma SA和Selexis SA在瑞士日内瓦启用一体化生物制剂设施，拓展欧洲市场
日内瓦 (美国商业资讯)–JSR Life Sciences旗下公司KBI Biopharma SA (KBI)和Selexis SA今天宣布，双方现已在瑞士日内瓦启用和运营一个经过扩建且完全一体化的哺乳动物合同开发和制造服务设施。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20220613005068/zh-CN/...
View ArticleClik here to view.
KBIバイオファーマとセレクシスがスイス・ジュネーブに統合的なバイオ医薬品製造施設を開設して欧州で拡大
ジュネーブ （ビジネスワイヤ） — いずれもJSRライフサイエンス傘下のKBIバイオファーマSA（KBI）とセレクシスは本日、スイスのジュネーブで完全統合型の哺乳類細胞受託開発製造サービス施設を拡張して開設したと発表しました。この施設は現在、稼働中です。...
View ArticleClik here to view.
GC Labs and Affiliates Participate in IFCC WorldLab Seoul 2022 as a Platinum...
YONGIN, South Korea GC Labs today announced that GC Labs and its affiliates including GC Cell, GC MS and GC Genome will participate in the IFCC WorldLab 2022 as a platinum sponsor held on 26-30 June...
View ArticleClik here to view.
HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to...
HONG KONG & INGELHEIM, Germany Hong Kong Science and Technology Parks Corporation (HKSTP) is partnering global research-driven biopharmaceutical leader, Boehringer Ingelheim Venture Fund Limited...
View ArticleClik here to view.
エクセンシア、健康なボランティアで選択的A2A受容体シグナル伝達阻害を示すEXS-21546の第1a相試験のトップラインデータを発表
英オックスフォード （ビジネスワイヤ） — エクセンシア（Nasdaq: EXAI）は本日、健康なボランティアでEXS-21546を検討する当社第1相試験から得たデータを発表しました。EXS-21546は、エクセンシアとイボテック（Frankfurt Stock Exchange: EVT、MDAX/TecDAX、ISIN: DE0005664809、Nasdaq:...
View ArticleClik here to view.
DEXLEVO’s 26 Billion Won Pre-IPO Spurs Global Marketing of ‘GOURI’
SEOUL, South Korea As the spread of COVID-19 has slowed down worldwide, the demand for skincare is expected to increase, and expectations for the rapid growth of the skincare market are also...
View ArticleClik here to view.
ウォーターズと BioInfra、分析スキル教育の促進を目的とした ASEAN バイオアナリシスアカデミー（ASEAN Academy for...
韓国、ソウル （ビジネスワイヤ） –ウォーターズコーポレーション（NYSE:WAT）は、医薬品・臨床分野の受託研究機関（CRO）のパイオニアである BioInfra と共同で、ASEAN バイオアナリシスアカデミー（ASEAN Academy for...
View ArticleClik here to view.
Waters and BioInfra Establish the ASEAN Academy for Bioanalysis to Promote...
SEOUL, South Korea Waters Corporation (NYSE:WAT) announced a collaboration with BioInfra, a pioneering contract research organization (CRO) company for the pharmaceutical and clinical fields, to...
View ArticleClik here to view.
Klick Health Announces Global Expansion
TORONTO & NEW YORK As the global advertising industry gathers at the Cannes Lions International Festival of Creativity, Klick Health today announced its global expansion. The large independent...
View ArticleClik here to view.
GS Global expands its portfolio with DEXLEVO for the EU and North America market
SEOUL, South Korea GS, which has announced its expansion into the bio business by acquiring Hugel, a botulinum toxin manufacturer, now seeks further business expansion. The group plans to diversify...
View ArticleClik here to view.
AiVF Raises $25 Million in Series A Round Led by Insight Partners to Help...
TEL AVIV, Israel AiVF®, developer of the first fully operational AI-based IVF software platform, announced today it has raised $25 million in a Series A round led by Insight Partners, a New...
View ArticleClik here to view.
Pictor Receives CE Mark for its PictArray™ SARS-CoV-2 Antibody Test,...
LOS ANGELES Following a recent funding round raising $6.1 million (NZD $8.8 million), biotech company Pictor today announced it has received confirmation of CE registration for its PictArray™...
View ArticleClik here to view.
AiVF、インサイト・パートナーズ主導のシリーズAラウンドで2500万ドルを調達し、親になれる人々が増えるよう支援
イスラエル・テルアビブ （ビジネスワイヤ） — 世界初の完全に運用可能なAIベース体外受精（IVF）ソフトウエアプラットフォームの開発元であるAiVF®は、ニューヨークを拠点とするベンチャーキャピタルでプライベート・エクイティ・ファンドのインサイト・パートナーズが主導し、アダム・ニューマン氏のファミリーオフィスである166 2nd...
View ArticleClik here to view.
Mary Kay Inc. Partners With the Society of Investigative Dermatology (SID) to...
DALLAS Mary Kay Inc., a global leader in skincare innovation, recently sponsored and revealed its inaugural Mary Kay Skin Health/Skin Disease Research Grants awardees for researchers conducting...
View ArticleClik here to view.
玫琳凯公司与皮肤病研究学会(SID)共同向学术研究人员颁发研究资助金，以促进皮肤健康研究
达拉斯 (美国商业资讯)–玫琳凯公司(Mary Kay Inc.)是护肤品创新的全球领导者。该公司最近在2022年皮肤病研究学会(SID)年会上赞助并公布了首届玫琳凯皮肤健康/皮肤病研究资助金获得者。他们均在皮肤健康和皮肤病方面进行了突破性的创新研究。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
玫琳凯在皮肤病研究学会会议上公布污染和皮肤健康新发现
达拉斯 (美国商业资讯)–护肤创新的全球领导者玫琳凯公司(Mary Kay Inc.)最近通过赞助2022年皮肤病研究学会(SID)年会并在活动中展示新的突破性研究，持续为美容和科学界提供支持。玫琳凯与纽约大学格罗斯曼医学院环境医学系合作的新发现表明，玫琳凯(Mary Kay®) TimeWise® Miracle Set 3D™护肤系列主打的抗氧化复合物可减少乡村污染和紫外线辐射的有害影响。...
View ArticleClik here to view.
AiVF在Insight Partners领投的A轮融资中筹得2500万美元，将帮助更多人成为父母
以色列特拉维夫 首个完全基于人工智能的试管受精软件平台的开发商AiVF®今天宣布，公司在总部位于纽约的风险投资和私募股权公司Insight Partners领投的A轮融资中筹集了2500万美元。Adam Neumann的家族办公室166 2nd参与了投资。 AiVF将利用这笔资金推动其人工智能平台EMA™在美国和欧洲的普及、扩大其员工队伍并开发更多的解决方案，以推动新一代数字化生育护理。...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Acquisition of an Injectable Product...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today...
View ArticleClik here to view.
Kubota Vision Announced End of Phase 3 Clinical Trial of Emixustat in...
SEATTLE Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the...
View Article